Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-9098
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens ; volume:31 ; number:4 ; day:18 ; month:8 ; year:2020 ; pages:495-501 ; date:12.2019
The Egyptian Journal of Internal Medicine ; 31, Heft 4 (18.8.2020), 495-501, 12.2019
- Urheber
-
Elsabaawy, Maha M.
Gameel, Khalid
Eldemerdash, Heba
Zakareia, Talaat
Eltahawy, Mahmoud
Albert, Marry
Fekry, Marwa
Ouda, Enas
Elshazly, Helmy
Eljaky, Ashraf
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.4103/ejim.ejim_80_19
- URN
-
urn:nbn:de:101:1-2021060508492514197391
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Elsabaawy, Maha M.
- Gameel, Khalid
- Eldemerdash, Heba
- Zakareia, Talaat
- Eltahawy, Mahmoud
- Albert, Marry
- Fekry, Marwa
- Ouda, Enas
- Elshazly, Helmy
- Eljaky, Ashraf
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression